New system provides greater efficiency and flexibility in managing
patient data and strengthens Phase IIb-IV offering
KING OF PRUSSIA, PA, April 6 /PRNewswire-FirstCall/ - MDS Pharma
Services, a leading provider of innovative drug discovery and development
solutions, has adopted DataLabs Clinical Electronic Data Capture (EDC) system
for increased efficiency and flexibility in managing patient data from
clinical trials in geographically diverse sites.
"The adoption of this new system reflects our commitment to strengthen
our Global Clinical Development line of business," said MDS Pharma Services
President, Gilbert Godin. "This technology enhances our ability to meet
growing client demand for our Phase IIb-IV clinical trial management services
and sharpens MDS Pharma Service's competitive positioning in this fast growing
market."
The DataLabs Clinical electronic data management system unifies the
functionality of paper data entry with the flexibility of EDC into one easy to
use, web-based electronic data management platform. The system allows MDS
Pharma Services to design a clinical study once, collect data either through
paper data entry or EDC, and clean and manage the data with the same system,
using virtually the same process.
"DataLabs is pleased to add MDS Pharma Services to our Contract Research
Organization (CRO) Partners Program," said DataLabs President, Jim Langford.
"DataLabs has become the leading software company for the CRO industry by
providing significant value in both our software and in our business model."
About MDS Pharma Services
MDS Pharma Services offers a full spectrum of resources to meet the drug
discovery and development needs of the pharmaceutical and biotechnology
industries. With numerous facilities strategically located around the world,
the company applies advanced scientific and technological expertise to each
stage of the drug discovery and development process - Early Stage: lead
optimization, pre-IND research, pharmaceutical and biopharmaceutical
development, early clinical research (bioequivalence, phases I-IIa) and
bioanalysis; and Late Stage: global clinical development (phases IIb-IV) and
central lab. For more information, visit MDS Pharma Services' Web site at
www.mdsps.com.
MDS Pharma Services is an integral part of MDS Inc. (TSX: MDS; NYSE:
MDZ). MDS Inc. has more than 8,800 highly skilled people in 27 countries. We
provide a diverse range of superior products and services to increase our
customers' speed, precision and productivity in the drug development and
disease diagnosis processes. We are a global, values-driven life sciences
company, recognized for our reliability and collaborative relationships as we
help create better outcomes in the treatment of disease. Find out more at
www.mdsinc.com or by calling 1-800-MDS-7222, 24 hours a day.
About DataLabs
DataLabs is an innovative developer of Web-based applications for
clinical development that helps the CRO and biopharmaceutical industries
accelerate clinical trials with proven software for electronic clinical data
management, electronic clinical collaboration, site management, and web based
eLearning software. Based on Microsoft platform technology, XML Web services
and CDISC ODM standards, the DataLabs Clinical product suite adapts to
established operating procedures and integrates easily with existing
technology systems. As a result, DataLabs Clinical customers enjoy a low total
cost of ownership and high return on investment. Major pharmaceutical
companies, government entities, healthcare organizations and contract research
organizations (CROs) are currently realizing time and cost savings using
DataLabs Clinical. DataLabs, a Microsoft Certified Partner, is based in
Irvine, Calif. with East Coast offices in Pennsylvania. Additional information
about DataLabs is available at www.datalabs.com.
SOURCE MDS Pharma Services
-0- 04/06/2006
/CONTACT: For Investors, Sharon Mathers, (416) 675-6777, ext. 2695,
sharon.mathers@mdsinc.com; For Media, Charlene McGrady,
(610) 239-7900, ext. 231, Charlene.Mcgrady@mdsps.com/
(MDS. MDZ)
CO: MDS Pharma Services; MDS Inc.
ST: Pennsylvania
IN: MTC
SU:
-30-
NC
-- TO298 --
5522 04/06/2006 08:00 EDT http://www.prnewswire.com
